Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

AIMS/HYPOTHESIS: An increased risk of fracture with canagliflozin vs placebo was reported from the CANagliflozin cardioVascular Assessment Study (CANVAS) Program, with heterogeneity of findings identified between the two trials that comprise the CANVAS Program, CANVAS and CANVAS-R. The objective of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetologia
Egile Nagusiak: Zhou, Zien, Jardine, Meg, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Desai, Mehul, Oh, Richard, Simpson, Roger, Watts, Nelson B., Neal, Bruce
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731200/
https://ncbi.nlm.nih.gov/pubmed/31399845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-019-4955-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak